<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000833'>Glucose intolerance</z:hpo> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is related to enhanced hepatic <z:chebi fb="105" ids="17234">glucose</z:chebi> production (HGP) due to the increased expression of hepatic gluconeogenic enzymes </plain></SENT>
<SENT sid="1" pm="."><plain>Previously, we revealed that hepatic STAT3 decreases the expression of hepatic gluconeogenic enzymes and suppresses HGP </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we show that increased plasma histidine results in hepatic STAT3 activation </plain></SENT>
<SENT sid="3" pm="."><plain>Intravenous and intracerebroventricular (ICV) administration of histidine-activated hepatic STAT3 reduced G6Pase protein and <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels and augmented HGP suppression by insulin </plain></SENT>
<SENT sid="4" pm="."><plain>This suppression of hepatic gluconeogenesis by histidine was abolished by hepatic STAT3 deficiency or hepatic Kupffer cell <z:mpath ids='MPATH_63'>depletion</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Inhibition of HGP by histidine was also blocked by ICV administration of a <z:chebi fb="11" ids="18295">histamine</z:chebi> <z:chebi fb="0" ids="37955">H1 receptor antagonist</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Therefore, histidine activates hepatic STAT3 and suppresses HGP via central <z:chebi fb="11" ids="18295">histamine</z:chebi> action </plain></SENT>
<SENT sid="7" pm="."><plain>Hepatic STAT3 phosphorylation after histidine ICV administration was attenuated in <z:chebi fb="11" ids="18295">histamine</z:chebi> H1 receptor-knockout (Hrh1KO) mice, but not in neuron-specific insulin receptor-knockout (NIRKO) mice </plain></SENT>
<SENT sid="8" pm="."><plain>Conversely, hepatic STAT3 phosphorylation after insulin ICV administration was attenuated in NIRKO, but not in Hrh1KO mice </plain></SENT>
<SENT sid="9" pm="."><plain>These findings suggest that central histidine action is independent of central insulin action, while both have additive effects on HGP suppression </plain></SENT>
<SENT sid="10" pm="."><plain>Our results indicate that central histidine/<z:chebi fb="11" ids="18295">histamine</z:chebi>-mediated suppression of HGP is a potential target for the treatment of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>